|
Our network includes a range of medical/scientific experts, key opinion leaders and investors, and if relevant we serve as liaison between client and potential partners.
We have also established a large network of technology transfer units, research institutions and companies highly active in health/biotechnological and pharmaceutical innovation, and we strive to bridge life science innovators and the commercial environment.
|